In a clinical study, Tadalafil altered anti-tumor immunity in patients with recurrent HNSCC by downregulating MDSCs and Tregs and increasing cytotoxic CD8+ T cell levels in both peripheral blood and tumor site (Weed et al., 2019). This evidence concerns the gene CD8A and neoplasm.